A review of deep learning methods for ligand based drug virtual screening

[1]  Huan Zhao,et al.  Automated 3D Pre-Training for Molecular Property Prediction , 2023, KDD.

[2]  Zeming Lin,et al.  Evolutionary-scale prediction of atomic level protein structure with a language model , 2022, bioRxiv.

[3]  Xing Chen,et al.  Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection , 2022, Briefings Bioinform..

[4]  Ka-chun Wong,et al.  CoaDTI: multi-modal co-attention based framework for drug-target interaction annotation , 2022, Briefings Bioinform..

[5]  Xiangrui Cai,et al.  Heterogeneous Graph Attention Network for Drug-Target Interaction Prediction , 2022, CIKM.

[6]  P. Pan,et al.  Boosting Protein-Ligand Binding Pose Prediction and Virtual Screening Based on Residue-Atom Distance Likelihood Potential and Graph Transformer. , 2022, Journal of medicinal chemistry.

[7]  Yang Shen,et al.  Cross-Modality and Self-Supervised Protein Embedding for Compound–Protein Affinity and Contact Prediction , 2022, bioRxiv.

[8]  Craig J. Neal,et al.  AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification , 2022, Briefings Bioinform..

[9]  J. Guan,et al.  Effective drug–target interaction prediction with mutual interaction neural network , 2022, Bioinform..

[10]  Yijie Ding,et al.  MLapSVM-LBS: Predicting DNA-binding proteins via a multiple Laplacian regularized support vector machine with local behavior similarity , 2022, Knowl. Based Syst..

[11]  Martin Ester,et al.  Ligand Binding Prediction Using Protein Structure Graphs and Residual Graph Attention Networks , 2022, bioRxiv.

[12]  Min Zeng,et al.  BridgeDPI: A Novel Graph Neural Network for Predicting Drug-Protein Interactions. , 2022, Bioinformatics.

[13]  S. Yiu,et al.  Compound-protein interaction prediction by deep learning: databases, descriptors and models. , 2022, Drug discovery today.

[14]  Yuedong Yang,et al.  Structure-Aware Multimodal Deep Learning for Drug-Protein Interaction Prediction , 2022, J. Chem. Inf. Model..

[15]  Evan E. Bolton,et al.  PubChem Protein, Gene, Pathway, and Taxonomy Data Collections: Bridging Biology and Chemistry through Target-Centric Views of PubChem Data. , 2022, Journal of molecular biology.

[16]  Hualiang Jiang,et al.  Graph neural network approaches for drug-target interactions. , 2022, Current opinion in structural biology.

[17]  D. Sundar,et al.  TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow , 2022, ACS omega.

[18]  Lu Zhao,et al.  MGraphDTA: deep multiscale graph neural network for explainable drug–target binding affinity prediction , 2022, Chemical science.

[19]  Meriem Belguidoum,et al.  EA-based hyperparameter optimization of hybrid deep learning models for effective drug-target interactions prediction , 2021, Expert Syst. Appl..

[20]  Jike Wang,et al.  InteractionGraphNet: A Novel and Efficient Deep Graph Representation Learning Framework for Accurate Protein-Ligand Interaction Predictions. , 2021, Journal of medicinal chemistry.

[21]  Jiming Chen,et al.  A unified drug–target interaction prediction framework based on knowledge graph and recommendation system , 2021, Nature Communications.

[22]  Jijun Tang,et al.  Drug-disease associations prediction via Multiple Kernel-based Dual Graph Regularized Least Squares , 2021, Appl. Soft Comput..

[23]  T. Nakaguchi,et al.  GVDTI: graph convolutional and variational autoencoders with attribute-level attention for drug-protein interaction prediction , 2021, Briefings Bioinform..

[24]  Qichang Zhao,et al.  HyperAttentionDTI: improving drug-protein interaction prediction by sequence-based deep learning with attention mechanism , 2021, Bioinform..

[25]  Tie-Yan Liu,et al.  Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer , 2021, Briefings Bioinform..

[26]  Guohua Wang,et al.  Drug-target interaction predication via multi-channel graph neural networks , 2021, Briefings Bioinform..

[27]  Zhiqiang Wei,et al.  SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network , 2021, International journal of molecular sciences.

[28]  Kenli Li,et al.  BioERP: biomedical heterogeneous network-based self-supervised representation learning approach for entity relationship predictions , 2021, Bioinform..

[29]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[30]  Lei Xu,et al.  Application of Machine Learning for Drug–Target Interaction Prediction , 2021, Frontiers in Genetics.

[31]  B. Berger,et al.  Learning the protein language: Evolution, structure, and function. , 2021, Cell systems.

[32]  Jijun Tang,et al.  Identification of drug-target interactions via multi-view graph regularized link propagation model , 2021, Neurocomputing.

[33]  Yangkun Cao,et al.  Autoencoder-based drug-target interaction prediction by preserving the consistency of chemical properties and functions of drugs , 2021, Bioinform..

[34]  Jike Wang,et al.  Mining Toxicity Information from Large Amounts of Toxicity Data. , 2021, Journal of medicinal chemistry.

[35]  Talia B. Kimber,et al.  Deep Learning in Virtual Screening: Recent Applications and Developments , 2021, International journal of molecular sciences.

[36]  Shirui Pan,et al.  GADTI: Graph Autoencoder Approach for DTI Prediction From Heterogeneous Network , 2021, Frontiers in Genetics.

[37]  Yaohang Li,et al.  DeepDTAF: a deep learning method to predict protein-ligand binding affinity , 2021, Briefings Bioinform..

[38]  Xinjiang Lu,et al.  GraphMS: Drug Target Prediction Using Graph Representation Learning with Substructures , 2021, Applied Sciences.

[39]  Sun Kim,et al.  A review on compound-protein interaction prediction methods: Data, format, representation and model , 2021, Computational and structural biotechnology journal.

[40]  Jianye Hao,et al.  An end-to-end heterogeneous graph representation learning-based framework for drug-target interaction prediction , 2021, Briefings Bioinform..

[41]  Jijun Tang,et al.  Exploring associations of non-coding RNAs in human diseases via three-matrix factorization with hypergraph-regular terms on center kernel alignment , 2021, Briefings Bioinform..

[42]  Jiangning Song,et al.  Computational identification of eukaryotic promoters based on cascaded deep capsule neural networks , 2020, Briefings Bioinform..

[43]  Shengyu Zhang,et al.  TrimNet: learning molecular representation from triplet messages for biomedicine , 2020, Briefings Bioinform..

[44]  Truyen Tran,et al.  GEFA: Early Fusion Approach in Drug-Target Affinity Prediction , 2020, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[45]  Jijun Tang,et al.  Identification of Drug-Target Interactions via Dual Laplacian Regularized Least Squares with Multiple Kernel Fusion , 2020, Knowl. Based Syst..

[46]  B. Rost,et al.  ProtTrans: Towards Cracking the Language of Life’s Code Through Self-Supervised Deep Learning and High Performance Computing , 2020, bioRxiv.

[47]  Qiming Fu,et al.  Empirical Potential Energy Function Toward ab Initio Folding G Protein-Coupled Receptors , 2020, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[48]  Andre Franke,et al.  Amino acid encoding for deep learning applications , 2020, BMC Bioinformatics.

[49]  Xiaofeng Wang,et al.  Drug–target affinity prediction using graph neural network and contact maps , 2020, RSC advances.

[50]  Arne Elofsson,et al.  TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments , 2020, Bioinform..

[51]  Jiajie Peng,et al.  Identifying drug-target interactions based on graph convolutional network and deep neural network , 2020, Briefings Bioinform..

[52]  Jimeng Sun,et al.  MolTrans: Molecular Interaction Transformer for drug–target interaction prediction , 2020, Bioinform..

[53]  M. Aljofan,et al.  An overview of drug discovery and development. , 2020, Future medicinal chemistry.

[54]  Nicholas Marshall,et al.  A Deep Dive into Machine Learning Models for Protein Engineering. , 2020, Journal of chemical information and modeling.

[55]  Dan Zhao,et al.  MONN: A Multi-objective Neural Network for Predicting Compound-Protein Interactions and Affinities , 2020, Cell Systems.

[56]  Hai-Cheng Yi,et al.  A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network , 2020, BMC Medical Informatics and Decision Making.

[57]  Xiangxiang Zeng,et al.  Network-based prediction of drug-target interactions using an arbitrary-order proximity embedded deep forest , 2020, Bioinform..

[58]  J. Reymond,et al.  SMILES-based deep generative scaffold decorator for de-novo drug design , 2020, Journal of Cheminformatics.

[59]  Kayvan Najarian,et al.  Machine learning approaches and databases for prediction of drug–target interaction: a survey paper , 2020, Briefings Bioinform..

[60]  Yang Liu,et al.  GANsDTA: Predicting Drug-Target Binding Affinity Using GANs , 2020, Frontiers in Genetics.

[61]  Mostafa Karimi,et al.  Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts , 2019, bioRxiv.

[62]  Bin Yu,et al.  Predicting drug-target interactions using Lasso with random forest based on evolutionary information and chemical structure. , 2019, Genomics.

[63]  Wenyu Chen,et al.  Prediction of drug-target interaction based on protein features using undersampling and feature selection techniques with boosting. , 2019, Analytical biochemistry.

[64]  Emile R Chimusa,et al.  Computational/in silico methods in drug target and lead prediction , 2019, Briefings Bioinform..

[65]  Yaohang Li,et al.  AttentionDTA: prediction of drug–target binding affinity using attention model , 2019, 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[66]  Mohammed AlQuraishi,et al.  AlphaFold at CASP13 , 2019, Bioinform..

[67]  Fei Guo,et al.  Identification of drug–target interactions via fuzzy bipartite local model , 2019, Neural Computing and Applications.

[68]  Ying Fu,et al.  Identification of novel inhibitors of p-hydroxyphenylpyruvate dioxygenase using receptor-based virtual screening , 2019, Journal of the Taiwan Institute of Chemical Engineers.

[69]  Priya Singh,et al.  Exploring the role of water molecules in the ligand binding domain of PDE4B and PDE4D:Virtual screening based molecular docking of some active scaffolds. , 2019, Current computer-aided drug design.

[70]  Xiaoli Li,et al.  Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey , 2019, Briefings Bioinform..

[71]  John Canny,et al.  Evaluating Protein Transfer Learning with TAPE , 2019, bioRxiv.

[72]  Heather A Carlson,et al.  Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing. , 2019, Journal of molecular biology.

[73]  Li Li,et al.  Predicting protein-ligand interactions based on bow-pharmacological space and Bayesian additive regression trees , 2019, Scientific Reports.

[74]  Myle Ott,et al.  Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences , 2019, Proceedings of the National Academy of Sciences.

[75]  Bin Li,et al.  Applications of machine learning in drug discovery and development , 2019, Nature Reviews Drug Discovery.

[76]  Yongjian Li,et al.  Predicting drug–protein interaction using quasi-visual question answering system , 2019, Nature Machine Intelligence.

[77]  Volkan Atalay,et al.  DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations , 2018, bioRxiv.

[78]  Russ B. Altman,et al.  Graph Convolutional Neural Networks for Predicting Drug-Target Interactions , 2018, bioRxiv.

[79]  Andrew R. Leach,et al.  ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..

[80]  Hojung Nam,et al.  DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences , 2018, PLoS Comput. Biol..

[81]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[82]  Antje Chang,et al.  BRENDA in 2019: a European ELIXIR core data resource , 2018, Nucleic Acids Res..

[83]  Tudor I. Oprea,et al.  DrugCentral 2018: an update , 2018, Nucleic Acids Res..

[84]  Stefano E. Rensi,et al.  Machine learning in chemoinformatics and drug discovery. , 2018, Drug discovery today.

[85]  Jun Sese,et al.  Compound‐protein interaction prediction with end‐to‐end learning of neural networks for graphs and sequences , 2018, Bioinform..

[86]  Ping Zhang,et al.  Interpretable Drug Target Prediction Using Deep Neural Representation , 2018, IJCAI.

[87]  Juho Rousu,et al.  Learning with multiple pairwise kernels for drug bioactivity prediction , 2018, Bioinform..

[88]  Di Wu,et al.  DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks , 2018, bioRxiv.

[89]  Namrata Anand,et al.  Generative modeling for protein structures , 2018, NeurIPS.

[90]  Arzucan Özgür,et al.  DeepDTA: deep drug–target binding affinity prediction , 2018, Bioinform..

[91]  Sabrina Jaeger,et al.  Mol2vec: Unsupervised Machine Learning Approach with Chemical Intuition , 2018, J. Chem. Inf. Model..

[92]  Saskia Preissner,et al.  SuperDRUG2: a one stop resource for approved/marketed drugs , 2017, Nucleic Acids Res..

[93]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[94]  Juho Rousu,et al.  Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors , 2017, PLoS Comput. Biol..

[95]  Lukasz Kaiser,et al.  Attention is All you Need , 2017, NIPS.

[96]  Yanli Wang,et al.  High-Throughput Screening Assay Datasets from the PubChem Database , 2017, Chemical informatics.

[97]  Artem Cherkasov,et al.  SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines , 2017, Journal of Cheminformatics.

[98]  Peng Chen,et al.  DrugRPE: Random projection ensemble approach to drug-target interaction prediction , 2017, Neurocomputing.

[99]  Vijay S. Pande,et al.  MoleculeNet: a benchmark for molecular machine learning , 2017, Chemical science.

[100]  David Ryan Koes,et al.  Protein-Ligand Scoring with Convolutional Neural Networks , 2016, Journal of chemical information and modeling.

[101]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[102]  Rajarshi Guha,et al.  Pharos: Collating protein information to shed light on the druggable genome , 2016, Nucleic Acids Res..

[103]  Keith C. C. Chan,et al.  Large-scale prediction of drug-target interactions from deep representations , 2016, 2016 International Joint Conference on Neural Networks (IJCNN).

[104]  Lukasz Kurgan,et al.  PDID: database of molecular-level putative protein-drug interactions in the structural human proteome , 2016, Bioinform..

[105]  Damian Szklarczyk,et al.  STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data , 2015, Nucleic Acids Res..

[106]  Shuigeng Zhou,et al.  Boosting compound-protein interaction prediction by deep learning , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[107]  Michael K. Gilson,et al.  BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..

[108]  Jie Li,et al.  PDB-wide collection of binding data: current status of the PDBbind database , 2015, Bioinform..

[109]  Jack A Tuszynski,et al.  A simple method for finding a protein’s ligand-binding pockets , 2014, BMC Structural Biology.

[110]  Tao Xu,et al.  Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis , 2014, J. Chem. Inf. Model..

[111]  Yasuo Tabei,et al.  Identification of chemogenomic features from drug–target interaction networks using interpretable classifiers , 2012, Bioinform..

[112]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[113]  Hua Yu,et al.  A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.

[114]  Andreas Bender,et al.  Recognizing Pitfalls in Virtual Screening: A Critical Review , 2012, J. Chem. Inf. Model..

[115]  Mindy I. Davis,et al.  Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.

[116]  Yoshihiro Yamanishi,et al.  Extracting Sets of Chemical Substructures and Protein Domains Governing Drug-Target Interactions , 2011, J. Chem. Inf. Model..

[117]  Sebastian G. Rohrer,et al.  Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data , 2009, J. Chem. Inf. Model..

[118]  Robert B. Russell,et al.  SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..

[119]  Natasja Brooijmans,et al.  Molecular recognition and docking algorithms. , 2003, Annual review of biophysics and biomolecular structure.

[120]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[121]  OUP accepted manuscript , 2022, Bioinformatics.

[122]  Karim Abbasi.  Deep Learning in Drug Target Interaction Prediction: Current and Future Perspectives , 2021, Current Medicinal Chemistry.

[123]  OUP accepted manuscript , 2021, Briefings In Bioinformatics.

[124]  OUP accepted manuscript , 2021, Briefings In Bioinformatics.

[125]  D. Salazar,et al.  Chapter 41 – Modern Drug Discovery and Development , 2017 .

[126]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..